New drug for prostate cancer patients extends life by 4.6 months. Wah, is that a great achievement?

SINGAPORE: A new drug to treat advanced stage prostate cancer may prolong lives and mitigate pain for patients whose conditions have worsened while on, or after chemotherapy.

Called Zytiga, the pill has been approved by the Health Sciences Authority of Singapore.

Prostate cancer is the third most common cancer among Singaporean men.

In global clinical trials, patients lived an average of 4.6 months longer after taking the drug.

Read more:

One professor sent me this note:  Increasing life span by 4.6 months using zytiga (abiraterone acetate) with accompanying side effects is said to be an achievement. It is ridiculous to any good academic.


Author: CA Care

In obedience to God's will and counting on His mercies and blessings, and driven by the desire to care for one another, we seek to provide help, direction and relief to those who suffer from cancer.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s